Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SD-OCT-guided Ranibizumab in Myopic CNV
NCT03409250Phase 4Completed
- Sponsor
- Vista Klinik
- Start
- Jun 2011
- Primary completion
- Jul 2014
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab in myopic choroidal neovascularization (mCNV), sponsored by Vista Klinik. Started Jun 2011; status: completed.
02
Drugs
ranibizumab
03
Conditions
myopic choroidal neovascularization (mCNV)
Beyond the preview
Go deeper on NCT03409250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03409250.